Project Grant HT94252410360
Award Date
6/15/24
Completion Date
6/14/28
Dollars Obligated
$5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
This $3,823,679 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and evaluation of a web-based training program for brief cognitive behavioral therapy (BCBT) for suicide prevention. The prime awardee, The Ohio State University, is collaborating with subrecipients The University of Texas Health Science Center at San Antonio, the Medical University of South Carolina, and the University of Memphis...
This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,326,715 to the Boston VA Research Institute, Inc. (BVARI) to develop and conduct a preliminary evaluation of a self-directed, internet-based Cognitive Processing Therapy (CPT) intervention. The funding period is from September 1, 2024 to August 31, 2028. The key products and services to be delivered under this grant include: Developing the web-based CPT...
This federal Project Grant award of $6,964,861, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the "INFORMING THE FUTURE OF PSYCHOLOGICAL HEALTH CARE IN THE MILITARY: THE STRONG STAR-CAP LONGITUDINAL OUTCOMES PROJECT" at the University of Texas Health Science Center at San Antonio (UTHSCSA). The key objectives of this 4-year research project include: 1) conducting longitudinal follow-up of 3,360 previous clinical...
This federal Project Grant award of $267,311 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The award was made to The Ohio State University, which will serve as the prime recipient, with a performance period from August 1, 2024 to July 31, 2027. The project aims to...
The Defense Health Agency awarded a $5,009,418 Project Grant to The Ohio State University under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from September 1, 2025 to August 31, 2029, supports the development and implementation of "The Core Competency Model-Military Version (CCM-MV): A Virtual Suicide Prevention Training Program." This virtual training program aims to transform healthcare for military service...
The Defense Health Agency awarded a four-year, $936,532 Cooperative Agreement to the University of Texas Health Science Center at San Antonio (UTHSCSA) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This award is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research to transform healthcare for service members and the public. Through this Cooperative Agreement, UTHSCSA will conduct research...
This federal Project Grant award, valued at $3,141,404.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The award was granted to Rush University Medical Center, a prominent academic medical center in Chicago, Illinois, to conduct this...
The Defense Health Agency awarded The Ohio State University a $8,375,496 cooperative agreement under the Military Medical Research and Development program (CFDA 12.420) from September 30, 2022 to September 29, 2026. This award will fund the Augmenting Suicide Prevention Interventions for Service Members project, which consists of five synergistic studies that aim to identify the strategies, delivery methods, providers, and circumstances most effective for preventing suicidality among military...